However, small-molecule inhibitors such as epacadostat can block IDO1 activity and restore anti-tumoral T cell immunity in mice, in synergy with immune checkpoint inhibitors or cancer vaccines (Peyraud et al., 2022). Here, IDO1 is linked to cancer.